Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H S Thompson

Showing results (151-160 of 160) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 160 results.
Neurology|April 1, 1989
Downbeating nystagmus and other ocular motor defects caused by lithium toxicityJ J Corbett, D M Jacobson, H S Thompson, et al.
Clinical and Experimental Immunology|April 1, 1988
Tolerogenic activity of polymerized type II collagen in preventing collagen-induced arthritis in ratsH S Thompson, B Henderson, J M Spencer, et al.
Archives of Neurology|August 1, 1982
Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual lossJ J Corbett, P J Savino, H S Thompson, et al.
Vaccine|March 17, 1999
Phase I safety and antigenicity of TA-GW: a recombinant HPV6 L2E7 vaccine for the treatment of genital wartsH S Thompson, M L Davies, F P Holding, et al.
AJNR. American Journal of Neuroradiology|January 1, 1992
Selective MR imaging approach for evaluation of patients with Horner's syndromeK B Digre, W R Smoker, P Johnston, et al.
Immunology|May 1, 1993
Prevention of pristane-induced arthritis by the oral administration of type II collagenS J Thompson, H S Thompson, N Harper, et al.
The Journal of Infectious Diseases|February 10, 1999
Phase IIa safety and immunogenicity of a therapeutic vaccine, TA-GW, in persons with genital wartsC J Lacey, H S Thompson, E F Monteiro, et al.
Journal of Autoimmunity|December 1, 1990
Low affinity antibodies against collagen type II are associated with pathology in collagen-induced arthritis in miceN A Staines, T A Ekong, H S Thompson, et al.
Vaccine|October 31, 1998
Enhanced immunogenicity of a recombinant genital warts vaccine adjuvanted with monophosphoryl lipid AH S Thompson, M L Davies, M J Watts, et al.
Public Health Genomics|May 5, 2011
Ethnic, racial and cultural identity and perceived benefits and barriers related to genetic testing for breast cancer among at-risk women of African descent in New York CityK M Sussner, T A Edwards, H S Thompson, et al.
Pageof 16

Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Neurology|April 1, 1989
Downbeating nystagmus and other ocular motor defects caused by lithium toxicityJ J Corbett, D M Jacobson, H S Thompson, et al.
Clinical and Experimental Immunology|April 1, 1988
Tolerogenic activity of polymerized type II collagen in preventing collagen-induced arthritis in ratsH S Thompson, B Henderson, J M Spencer, et al.
Archives of Neurology|August 1, 1982
Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual lossJ J Corbett, P J Savino, H S Thompson, et al.
Vaccine|March 17, 1999
Phase I safety and antigenicity of TA-GW: a recombinant HPV6 L2E7 vaccine for the treatment of genital wartsH S Thompson, M L Davies, F P Holding, et al.
AJNR. American Journal of Neuroradiology|January 1, 1992
Selective MR imaging approach for evaluation of patients with Horner's syndromeK B Digre, W R Smoker, P Johnston, et al.
Immunology|May 1, 1993
Prevention of pristane-induced arthritis by the oral administration of type II collagenS J Thompson, H S Thompson, N Harper, et al.
The Journal of Infectious Diseases|February 10, 1999
Phase IIa safety and immunogenicity of a therapeutic vaccine, TA-GW, in persons with genital wartsC J Lacey, H S Thompson, E F Monteiro, et al.
Journal of Autoimmunity|December 1, 1990
Low affinity antibodies against collagen type II are associated with pathology in collagen-induced arthritis in miceN A Staines, T A Ekong, H S Thompson, et al.
Vaccine|October 31, 1998
Enhanced immunogenicity of a recombinant genital warts vaccine adjuvanted with monophosphoryl lipid AH S Thompson, M L Davies, M J Watts, et al.
Public Health Genomics|May 5, 2011
Ethnic, racial and cultural identity and perceived benefits and barriers related to genetic testing for breast cancer among at-risk women of African descent in New York CityK M Sussner, T A Edwards, H S Thompson, et al.
Pageof 16